InsiderClue
Stocks · Health care · Services-Misc Health & Allied Services, NEC

Charming Medical Ltd

MCTA Clue Score28
Hong Kong CIK 0002035992
$29.36 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $29.36 +319.36% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Oct 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue6.0Operating income1.0Net income0.8EPS, diluted0.05Fiscal year 2025Revenue6.2 +3.4%Operating income1.4Net income1.2 +54.2%EPS, diluted0.08 +60.0%Fiscal year 2026Revenue4.8 −22.7%Operating income−0.0Net income−0.0 −101.9%EPS, diluted0.00 −100.0%
FY2024FY2025FY2026
Revenue 6.0 6.2 4.8
Growth +3.4% −22.7%
Operating income 1.0 1.4 −0.0
Net income 0.8 1.2 −0.0
Growth +54.2% −101.9%
EPS, diluted 0.05 0.08 0.00
Growth +60.0% −100.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2024Operating margin16.8%Net margin12.9%Free cash flow margin1.4%Fiscal year 2025Operating margin22.3%Net margin19.3%Free cash flow margin2.2%Fiscal year 2026Operating margin−0.6%Net margin−0.5%Free cash flow margin−32.4%
FY2024FY2025FY2026
Operating margin 16.8% 22.3% −0.6%
Net margin 12.9% 19.3% −0.5%
Free cash flow margin 1.4% 2.2% −32.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow0.3Capital expenditure−0.2Free cash flow0.1Fiscal year 2025Operating cash flow0.4Capital expenditure−0.3Free cash flow0.1 +63.1%Fiscal year 2026Operating cash flow−1.2Capital expenditure−0.3Free cash flow−1.6 −1,224.2%
FY2024FY2025FY2026
Operating cash flow 0.3 0.4 −1.2
Capital expenditure −0.2 −0.3 −0.3
Free cash flow 0.1 0.1 −1.6
Growth +63.1% −1,224.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2024Cash2.1Shareholders’ equity−1.1Fiscal year 2025Cash0.8Shareholders’ equity0.0Fiscal year 2026Cash4.7Total debt0.2Net cash (debt)4.5Shareholders’ equity5.2Debt to equity0.04
FY2024FY2025FY2026
Cash 2.1 0.8 4.7
Total debt n/a n/a 0.2
Net cash (debt) n/a n/a 4.5
Shareholders’ equity −1.1 0.0 5.2
Debt to equity n/a n/a 0.04

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Revenue and profit
6.0 6.2 4.8
Growth +3.4% −22.7%
0.0 0.0 0.0
1.0 1.4 −0.0
Growth +37.7% −102.1%
1.0 1.4 0.1
0.2 0.2 0.2
0.8 1.2 −0.0
Growth +54.2% −101.9%
Per share
0.05 0.08 0.00
0.05 0.08 0.00
Growth +60.0% −100.0%
15.3 15.3 16.2
15.3 15.3 16.2
Growth +0.0% +5.3%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 1 of 3 years on file.